Last reviewed · How we verify

NCT06800001

Efficacy of Physical Activity for the Management of Stereotyped Behavior and Anxiety in Children With Autism Spectrum Disorder

Completed NA Last updated 29 January 2025
What this trial tests

NA trial testing Physical Activity in Autism Spectrum Disorder (ASD) in 40 participants. Completed in 30 December 2024.

Timeline
21 August 2024
Primary endpoint
30 December 2024
30 December 2024

Quick facts

Lead sponsorFatima Jinnah Women University
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingdouble
Primary purposehealth services research
Enrollment40
Start date21 August 2024
Primary completion30 December 2024
Estimated completion30 December 2024
Sites1 location across Pakistan

Drugs / interventions tested

Conditions studied

Sponsor

Fatima Jinnah Women University

Who can join

Adults 8 to 12, any sex, with Autism Spectrum Disorder (ASD) or Stereotyped Behavior. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The primary purpose of the study is to investigate whether physical activity can significantly manage stereotyped behavior and anxiety in children diagnosed with Autism Spectrum Disorder (ASD). The study aims to contribute to the existing literature by providing robust evidence on the efficacy of Physical Activity intervention for ASD, which could inform clinical practices and improve treatment outcomes.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Physical Activity

Trials testing the same drug.

Other recruiting trials for Autism Spectrum Disorder (ASD)

Currently open trials in the same condition.

Other Fatima Jinnah Women University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06800001.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing